Opsonization of pneumococci. II. Metabolic effects of a "third" human serum activity that mediates intracellular...

Area of Science:

• Immunology
• Microbiology
• Cell Biology

Background:

• Polymorphonuclear leukocytes (PMN) are critical for innate immunity against bacterial pathogens like Streptococcus pneumoniae.
• Serum factors, including complement and immunoglobulins, are known to enhance PMN-mediated bacterial killing.
• The existence of an additional, unidentified serum activity mediating pneumococcal killing by PMN has been suggested.

Purpose of the Study:

• To elucidate the specific role of a non-complement, non-immunoglobulin serum activity in the killing of pneumococci by PMN.
• To determine whether this serum activity is involved in bacterial attachment, ingestion, oxidative burst, or intracellular killing.
• To characterize the mechanisms by which this serum factor contributes to host defense against pneumococcal infections.

Main Methods:

• Electron microscopy was used to visualize pneumococci within PMN under various serum conditions.
• Radiolabeled bacteria were employed to quantify bacterial uptake by PMN.
• Oxygen consumption and hexose monophosphate shunt activation were measured to assess PMN oxidative responses.
• Nitroblue tetrazolium (NBT) reduction and cytochrome c reduction assays were performed to evaluate oxidative activity.
• Beta-glucuronidase release was measured as an indicator of PMN degranulation and phagocytosis.
• Cytochalasin B was used to differentiate between phagocytosis-dependent and independent cellular responses.

Main Results:

• Electron microscopy confirmed pneumococcal presence within PMN across all tested serum conditions (normal, absorbed, absorbed plus heat-inactivated).
• Bacterial uptake, oxygen consumption, and hexose monophosphate shunt activation by PMN were unaffected by the removal or inactivation of the 'third' serum activity.
• Reduction of NBT and cytochrome c, as well as protein iodination, were significantly reduced in the absence of the 'third' serum activity, indicating its role in oxidative killing.
• Beta-glucuronidase release and cytochrome c reduction in cytochalasin B-treated PMN were similar across all serum conditions, suggesting the factor acts intracellularly.
• The 'third' serum activity is not required for pneumococcal attachment, ingestion, or stimulation of the plasma membrane oxidase.

Conclusions:

• The unidentified serum activity is essential for the intracellular killing of pneumococci by PMN.
• This factor does not influence the initial stages of phagocytosis or the activation of the PMN oxidative burst.
• The findings highlight a novel mechanism of host defense involving a specific serum component that potentiates the intracellular bactericidal capacity of PMN.